Sacubitril Hemicalcium
沙库比曲半钙盐 | Sacubitril Hemicalcium | 1369773-39-6 | Cikin Gida |
沙库比曲钠盐 | 149690-05-1 | Cikin Gida | |
LCZ-4 | 1426129-50-1 | Cikin Gida | |
LCZ-7 | 1012341-48-8 | Cikin Gida | |
LCZ-8 | 1012341-50-2 | Cikin Gida | |
LCZ-9 | 149690-12-0 | Cikin Gida |
Fage
AHU-377 gishiri hemicalcium shine nau'in gishirin hemicalcium na AHU-377.Yana da mai hana neprilysin tare da ƙimar IC50 na 5 nM [1].
AHU-377 da angiotensin II AT1 antagonist valsartan sun tsara LCZ696 a cikin rabon molar 1:1.LCZ696 shine mai hanawa neprilysin mai karɓa na angiotensin.Yana iya rage hawan jini kuma yana iya zama sabon magani don maganin ciwon zuciya.AHU-377 pro-magunguna ne, ana iya jujjuya shi ta hanyar ɓarnawar enzymatic na ethyl ester zuwa nau'i mai aiki LBQ657.An ba da rahoton cewa AHU-377 (30 da 100 mg / kg, PO) na iya haifar da sakamako na antihypertensive a cikin nau'i mai dogara da kashi a cikin ratsan DAHI-SS.Amma a cikin DOCA-gishiri masu hawan jini, yana nuna raguwa mai rauni [2, 3].
Magana:
[1] Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.J Med Chem.1995 Mayu 12;38 (10): 1689-700.
[2] Voors AA, Dorhout B, van der Meer P. Matsayi mai yuwuwar valsartan + AHU377 (LCZ696) a cikin maganin cututtukan zuciya.Ra'ayin Kwararru Na Binciken Magunguna.2013 Agusta; 22 (8): 1041-7.
[3] Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi et al.Ingancin kwatancen AHU-377, mai hanawa neprilysin mai ƙarfi, a cikin nau'ikan bera guda biyu na hawan jini mai dogaro da ƙara.BMC Pharmacology 2011, 11 (Kashi 1):P33.
Tsarin sinadaran
Shawara18Ayyukan Ƙididdigar Ƙirar Ƙirar da aka amince da su4, kuma6ayyukan suna ƙarƙashin amincewa.
Babban tsarin kula da ingancin ingancin ƙasa ya kafa tushe mai ƙarfi don siyarwa.
Ingantacciyar kulawa tana gudanar da duk tsawon rayuwar samfurin don tabbatar da inganci da tasirin warkewa.
Mawakan da ake gudanarwa na kwararru yana tallafawa ingancin bukatun yayin aikace-aikacen da rajista.